Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program 2022-07-25 21:59
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA 2022-07-25 18:47
Fuzhou Rides on the Opportunity of "Digital China" to Make Its Name in the World 2022-07-25 15:21
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform 2022-07-25 12:30
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Handheld Technology from Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings 2022-07-25 08:30
US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL 2022-07-25 07:09
4DMedical Lauds U.S. House of Representatives for Including Burn Pit Population Surveillance in FY 2023 Appropriations 2022-07-23 00:59
Merck Launches its Uptune Program in Asia for Collaborating with Startups 2022-07-22 14:37
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada 2022-07-22 07:59
Congratulations! Kexing Biopharm (688136.SH) was awarded by the" Annual Top 20 Chinese Biopharmaceutical Entreprises" 2022-07-21 22:32
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy 2022-07-21 21:25
AI-based Cancer Solution Pioneer Lunit Makes Market Debut 2022-07-21 21:00
Mentice publishes the company's interim report for the period April - June 2022 2022-07-21 14:49
BAXTER HEALTHCARE ANNOUNCES STEVEN FLYNN TO LEAD ASIA PACIFIC REGION 2022-07-21 09:58
Telix Reports Second Quarter 2022 Financial Results 2022-07-21 08:34
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
First report from the world's most ambitious sequencing project 2022-07-20 23:00
ABCAM PLC First Half Trading Update 2022-07-20 21:50
1 227 228 229 230 231 894